|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$84.99 |
$85.25 |
$83.84 |
$84.11 |
919.10K | 03/22/2024 |
$84.35 |
$85.29 |
$83.90 |
$85.13 |
876.70K | 03/25/2024 |
$84.70 |
$86.99 |
$84.70 |
$86.52 |
1.41M | 03/26/2024 |
$86.94 |
$87.86 |
$86.50 |
$87.74 |
1.35M | 03/27/2024 |
$88.18 |
$88.74 |
$87.92 |
$88.61 |
1.03M |
|
BioMarin Pharmaceutical is a global biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products include: Vimizim (elosulfase alpha); Naglazyme (galsulfase); Kuvan (sapropterin dihydrochloride); Palynziq (pegvaliase-pqpz); Brineura (cerliponase alfa); Voxzogo (vosoritide); and Aldurazyme (laronidase). Co.'s clinical development programs include: Valoctocogene roxaparvovec, which is an adeno associated virus (AAV5) vector drug development candidate; BMN 307, which is an AAV5 mediated gene therapy; and BMN 225, which is a small-molecule therapy. | |
|
BioMarin Pharmaceutical (BMRN) has the following price history information. Looking back at BMRN historical stock prices for the last five trading days, on March 21, 2024, BMRN opened at $84.99, traded as high as $85.25 and as low as $83.84, and closed at $84.11. Trading volume was a total of 919.10K shares. On March 22, 2024, BMRN opened at $84.35, traded as high as $85.29 and as low as $83.90, and closed at $85.13. Trading volume was a total of 876.70K shares. On March 25, 2024, BMRN opened at $84.70, traded as high as $86.99 and as low as $84.70, and closed at $86.52. Trading volume was a total of 1.41M shares. On March 26, 2024, BMRN opened at $86.94, traded as high as $87.86 and as low as $86.50, and closed at $87.74. Trading volume was a total of 1.35M shares. On March 27, 2024, BMRN opened at $88.18, traded as high as $88.74 and as low as $87.92, and closed at $88.61. Trading volume was a total of 1.03M shares.
BMRN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into BioMarin Pharmaceutical shares, starting with a $10,000 purchase of BMRN, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$68.21 |
|
End price/share: |
$88.61 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
29.91% |
|
Average Annual Total Return: |
2.65% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$12,988.48 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/21/2024 | $84.11 | 03/22/2024 | $85.13 | 03/25/2024 | $86.52 | 03/26/2024 | $87.74 | 03/27/2024 | $88.61 |
|
|